Cogent Biosciences, Inc.·4

Jun 8, 4:43 PM ET

Shegog Todd 4

4 · Cogent Biosciences, Inc. · Filed Jun 8, 2023

Insider Transaction Report

Form 4
Period: 2023-06-07
Shegog Todd
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-07+36,70036,700 total
    Exercise: $11.70Exp: 2033-06-07Common Stock (36,700 underlying)
Footnotes (1)
  • [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION